MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2026 International Congress

    A composite oculomotor biomarker for differentiating Parkinson’s disease from multiple system atrophy

    M. Wójcik-Pędziwiatr, D. Hemmerling, J. Sikora, J. Stępień, W. Szecówka, M. Baran, M. Rudzińska-Bar (Kraków, Poland)

    Objective: To evaluate whether a composite oculomotor index integrating multiple eye movement domains improves discrimination between PD and MSA. Background: Differentiating Parkinson’s disease (PD) from…
  • 2026 International Congress

    Clinical Significance of Imaging Markers for Cerebellar Ataxia and Parkinsonism in Multiple System Atrophy

    Y. Nakano, A. Sugiyama, Y. Nakagawa, M. Tamura, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, K. Osawa, T. Yamamoto, Y. Yamanaka, M. Mori, S. Hirano (Chiba, Japan)

    Objective: To clarify the interactions among clinical features and imaging markers, and to identify factors contributing to disease severity in MSA. Background: Multiple system atrophy…
  • 2026 International Congress

    Assessment of dysautonomia in patients with sporadic adult-onset ataxia

    N. Joksimović, N. Mazalica, N. Krstić, U. Lazić, A. Milovanović, I. Pavlović, N. Dragaševic, I. Stanković (Belgrade, Serbia)

    Objective: The aim of this study was to assess prevalence and severity of autonomic dysfunction in patients with SAOA, defined as a subacute or progressive…
  • 2026 International Congress

    Multi-Sequence MRI-Based Machine Learning Model for Differentiating Parkinson Disease (PD) from Multiple System Atrophy (MSA)

    Y. Wang, N. He, M. Haacke, F. Yan, G. Yang, P. Lewitt (Shanghai, China)

    Objective: To develop a multi-sequence MRI-based machine learning model differentiating PD from MSA. Background: MRI protocols capable of distinguishing PD from MSA are greatly needed.…
  • 2026 International Congress

    Determinants of Re-diagnosis of Parkinson’s Disease to Atypical Parkinsonism: Results from the Tracking Parkinson’s Cohort (PRoBAND) and Oxford Parkinson’s Discovery Cohort (OPDC) Cohorts

    R. Fumi, D. Vaughan, T. Rittman, J. Rowe, E. Jabbari, A. Nodehi, M. Lawton, T. Zerenner, Y. Ben-Shlomo, D. Grosset, M. Hu, H. Morris (London, United Kingdom)

    Objective: We aim to identify the clinical and biomarker features which best predict re-diagnosis to a Parkinson plus syndrome (PPS) in those initially diagnosed with…
  • 2026 International Congress

    Choroid Plexus Morphology and Enhancement as Imaging Markers for Early Differentiation of Multiple System Atrophy and Parkinson’s Disease

    S. Jo, D. Ambaye, M. Choi, G. Lee, S. Chung, E. Lee, H. Cho (Seoul, Republic of Korea)

    Objective: To characterize choroid plexus (ChP) morphology and enhancement in multiple system atrophy (MSA) and Parkinson’s disease (PD), investigate their associations with ventricular morphology and…
  • 2026 International Congress

    Real-World Survival, Healthcare Access, and Medication Patterns in Atypical Parkinsonian Disorders: A Multi-System EHR Analysis

    J. Fenn, N. Mcfarland (Gainesville, USA)

    Objective: To assess regional prevalence, demographics, survival, neurology access, and medication utilization in atypical parkinsonian disorders. Background: Progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and…
  • 2026 International Congress

    Pain in Multiple System Atrophy: a healthcare professionals’ survey

    N. Campese, B. Caliò, F. Leys, D. Bendetowicz, G. Calandra Buonaura, K. Ray Chaudhuri, E. Coon, JC. Curtis, G. Deuschl, G. Devigili, R. Eleopra, M. Fabbri, C. Falup-Pecurariu, R. Freeman, F. Gandor, G. Göbel, P. Guaraldi, G. Höglinger, H. Kaufmann, A. Pavy-Le Traon, J. Levin, S. Lorenzl, WG. Meissner, V. Mylius, MT. Pellecchia, W. Poewe, A. Schlager, A. Schrag, K. Seppi, M. Tinazzi, J. Wanschitz, L. Zamarian, A. Fanciulli (Innsbruck, Austria)

    Objective: To appraise current knowledge, screening and treatment habits on pain in multiple system atrophy (MSA) among allied healthcare professionals (HCPs). Background: Pain is a…
  • 2026 International Congress

    Cortical Mean Diffusivity as a Measure of Microstructural Neurodegeneration in Multiple System Atrophy

    J. Pardo, V. Montal, C. Martín-Barceló, I. Roura, C. García-Vicente, C. Falcon, A. Campabadal, R. Sala-Llonch, N. Bargalló, J. Fortea, C. Painous, A. Pérez, A. Cámara, Y. Compta, C. Junqué, B. Segura, MJ. Martí (Barcelona, Spain)

    Objective: To characterize cortical microstructural alterations in multiple system atrophy (MSA) and to examine their associations with clinical features and neuropsychological performance. Background: Cortical mean…
  • 2026 International Congress

    Dynamic and Multimodal Prediction of Phenoconversion to Cerebellar Multiple Sytem Atrophy among Sporadic Late-Onset Cerebellar Ataxia

    T. Wirth, A. Storck, T. Bogdan, I. Pei, IJ. Namer, S. Kremer, C. Tranchant, M. Anheim (Strasbourg, France)

    Objective: To dynamically predict phenoconversion from a sporadic late-onset cerebellar ataxia (SLOCA) phenotype to MSA-C. Background: Cerebellar multiple system atrophy (MSA-C) is diagnosed according to…
  • 1
  • 2
  • 3
  • …
  • 28
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley